Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia
This study evaluates 21-day risk of myocarditis/pericarditis following COVID-19 vaccination among those aged 12 years and older in Malaysia. We used data from nationwide COVID-19 vaccine registry linked to hospital episode database to identify individuals vaccinated with BNT162b2, CoronaVac, or ChAd...
Main Authors: | Norazida Ab Rahman, Ming Tsuey Lim, Fei Yee Lee, Emelyne Bani Anak Jam, Kalaiarasu M Peariasamy, Sheamini Sivasampu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S259013622300044X |
Similar Items
-
Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study
by: Norazida Ab Rahman, et al.
Published: (2023-11-01) -
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
by: Jing Lian Suah, et al.
Published: (2022-06-01) -
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection
by: Jing Lian Suah, et al.
Published: (2022-12-01) -
The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine
by: Yishay Wasserstrum, et al.
Published: (2022-10-01) -
Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
by: Manan Pareek, et al.
Published: (2023-11-01)